Endotoxin and pyrogen test service
Based on long lasting experience
Based on long lasting experience in endotoxin and pyrogen testing, Microcoat offers a set of proprietary methods and skilled scientific personnel for non-routine projects. Services are run as flexible customer-specified projects including the search for root causes, exploration of realization alternatives, development of product-specific adaptions and validation of newly established methods.
Low endotoxin recovery
LER (low endotoxin recovery) was first reported in 2013 (Chen et al. 2013) and describes the observation that endotoxin is underestimated due to masking in various drug product formulations with time. Reports exist where spiked endotoxin in drug formulations was not detectable by LAL but were pyrogenic in rabbit pyrogen test.
Typical formulations comprise a protein component, polysorbate, citrate or phosphate. The effect is strongly dependend on storage temperature, duration of storage, nature of the API and source of spiked endotoxin.
A LER hold-time study performed in our lab includes a detailed project plan and report. The experimental setup will be aligned with your specific needs. The turnaround time depends on the duration of the experimental phase but we guaranty short processing time for preparation of the study and generation of the report (in general 4 weeks).
Requests from FDA for biologics
As reported by the FDA, classical endotoxin test methods (LAL) can fail to detect masked endotoxin in various drug formulations (low endotoxin recovery).
In 2013 Hyglos GmbH launched a sample preparation kit for the demasking of endotoxin in biopharmaceuticals, EndoRS(1). The new method is based on the combinatorial use of the kit components for the screening for the best demasking mixture. The kit has to be applied in combination with EndoLISA detection method.
Routine sample measurement
Endotoxin and pyrogen testing is mandatory during process development, as in-process control and for product release in pharmaceutical and medical device industry. In research (cell culture experiments and animal trails) contaminating endotoxins and other pyrogenic substances induce severe physiological reactions which often lead to false interpretation.
Microcoat has established a variety of commercial assays in order to narrow down the true nature of a contamination in a given sample. This may help to avoid false positive results and to provide improved strategies in process development and trouble shooting (OOS analysis). For differential testing two or more of the following assays may be applied:
The kinetic LAL reagent is based on a cell lysate generated from the blood of the horseshoe crab, Limulus polyphemus. The lysate is containing a blood clotting enzyme cascade which is specifically activated by the interaction of endotoxin with Factor C. The activated Factor C activates Factor B and Factor B activates proclotting enzyme. The activated proclotting enzyme releases a dye from a chromogenic peptide substrate. Proclotting enzyme is also activated by ß-Glucan via the specific receptor Factor G.
Recombinant Factor C assay
Homogeneous in vitro assay. The assay reagent is containing a recombinant Factor C from horseshoe crab which becomes specifically activated by endotoxin. Activated Factor C is converting a peptide substrate and thereby releasing a fluorescent dye.
If not differently requested, the recombinant Factor C assay (EndoZyme®) from Hyglos GmbH is used for analysis.
Specific endotoxin test based on ELISA principle. Endotoxin is bound to a microwell plate by a LPS-specific phage protein. After washing off the sample matrix, bound LPS is detected using a recombinant Factor C and a chromogenic peptide substrate. EndoLISA® from Hyglos GmbH is used for analysis.
Monocyte activation test
The Monocyte acitivation test (MAT) is a cell-based assay: Toll-like receptor mediated stimulation of blood monocytes to produce pro-inflammatory cytokines in response to various pyrogens. The level of released interleukin-1ß is determined by a classical IL-1ß ELISA.
Monocyte Activation Test from different vendors are used:
MAT Proficiency Test Program
We offer quality assurance to laboratories working with Monocyte Activation Test (MAT). Based on our expertise we provide frequently audits of MAT test proficiency. Our Proficiency Test Program (PTP) confidentially verifies working procedures, method and report validation, identifies trends and potential demands for training. This supplies additional value to internal quality assurance.
- Check and validate analysis techniques
- Verify conformity of procedures to requirements of the Pharmacopoeia
- Control and correct possible drift in procedural compliance
- Verify laboratory’s ability to recover correct level of contamination
- Compare results to those of other laboratories and other MAT methods
Get Started Today
Time Line for the 1st PTP trial:
Dear participants and interested parties,
The MAT PTP only works with your help, so despite the difficult times and limited operation, we decided to actively loosen the timelines for the MAT PTP, to react on the rising cases and widespread of COVID-19.
Registration will be extended to the 17-July -2020 and samples will be sent to you accordingly.
Provision of results will be extended approximately to the 01-August-2020.
Distribution of final report will be extended approximately to 01-September-2020
These are only a preliminary dates, which will be further extended until every result will be handed in – we will keep you posted about the final date and the distribution of the reports.
This assay uses a specially treated limulus amebocyte lysate (LAL) where the Factor C stimulation pathway is inhibited. Therefore only activation by ß-glucan via Factor G leads to activation of proclotting enzyme and conversion of the chromogenic substrate.
The ß-glucan assay from Associates of Cape Cod (Glucatell®) is used for analysis.
Microcoat provides consulting service in the field of pyrogen and bacterial endotoxin testing. Our team is specialized in the implementation of alternative test methods and provides advice in the case of test interference. For the analysis of the Low Endotoxin Recovery (LER) phenomenon, we provide dedicated guidance in planning, performing and interpreting of hold-time studies. Always giving you advice and quick support if you are facing unexpected trouble during execution of your studies. Furthermore, we support you in the development of strategies for mitigation of LER-affected products according to regulatory requirements.